Name two common electrolyte changes seen in PD patients and their management considerations.

Name two common electrolyte changes seen in PD patients and their management considerations.

• A. Potassium disturbances (usually removal leading to risk of hypokalemia) and phosphate depletion (hypophosphatemia); monitor serum K and phosphate and adjust dialysate potassium concentration and phosphate binders as needed.
• B. Only sodium changes.
• C. Chloride changes.
• D. Calcium increases only.

Answer: (A)

In peritoneal dialysis, what moves in and out of the body is driven by the dialysate composition and the properties of the peritoneal membrane. Two common electrolyte patterns you’ll see are potassium disturbances and phosphate depletion. Potassium tends to be removed with PD because standard solutions are potassium-free or low in potassium, so potassium diffuses from blood into the dialysate and is carried away with outflow. This can put patients at risk for hypokalemia, especially with longer dwell times, aggressive ultrafiltration, or when dietary potassium is restricted. The key management step is to monitor serum potassium and tailor the dialysate potassium concentration accordingly to prevent dangerous lows. Phosphate is also cleared by PD, and effective phosphate removal can lead to hypophosphatemia. Hypophosphatemia can affect energy and bone health, so the plan is to monitor serum phosphate and adjust therapy as needed—this may mean reducing or stopping phosphate binders if levels are too low, or, if phosphate is high, increasing binder use or modifying the dialysis prescription to improve control. In short, the two common electrolyte changes are potassium depletion and phosphate depletion, with ongoing monitoring and selective adjustments to dialysate potassium and phosphate binder therapy guiding management.

In peritoneal dialysis, what moves in and out of the body is driven by the dialysate composition and the properties of the peritoneal membrane. Two common electrolyte patterns you’ll see are potassium disturbances and phosphate depletion. Potassium tends to be removed with PD because standard solutions are potassium-free or low in potassium, so potassium diffuses from blood into the dialysate and is carried away with outflow. This can put patients at risk for hypokalemia, especially with longer dwell times, aggressive ultrafiltration, or when dietary potassium is restricted. The key management step is to monitor serum potassium and tailor the dialysate potassium concentration accordingly to prevent dangerous lows.

Phosphate is also cleared by PD, and effective phosphate removal can lead to hypophosphatemia. Hypophosphatemia can affect energy and bone health, so the plan is to monitor serum phosphate and adjust therapy as needed—this may mean reducing or stopping phosphate binders if levels are too low, or, if phosphate is high, increasing binder use or modifying the dialysis prescription to improve control. In short, the two common electrolyte changes are potassium depletion and phosphate depletion, with ongoing monitoring and selective adjustments to dialysate potassium and phosphate binder therapy guiding management.